Contact Us
 • 
Home
Search 

Welcome

UK Early Detection Initiative for Pancreatic Cancer

UK-EDI is a research programme funded by Cancer Research UK which will explore the link between new-onset diabetes and pancreatic cancer with the aim of finding ways to diagnose pancreatic cancer earlier.

Most cases of type 2 diabetes are due to lifestyle or genetic factors. However, in approximately 1% of people, a new diagnosis of type 2 diabetes could be an early warning sign of pancreatic cancer.

Through this research we hope to develop a diagnostic test for use in individuals newly diagnosed with diabetes which will identify those most at risk of pancreatic cancer, allowing them to be screened.

The aim of UK-EDI is to detect pancreatic cancer earlier.

UK-EDI consists of seven work packages that contribute to the overall aim of the programme.

UK-EDI is hosted by the University of Liverpool in collaboration with the Liverpool Clinical Trials Centre (LCTC), Liverpool GCP labs, Liverpool ECMC (Liverpool PHPB centre) and the University of Strathclyde.

 


 

 

 

.

 


 

 

 

If you are interested in finding out how we handle your personal data please visit this site https://lctc.org.uk/privacy

 


 

 

 

.

 


 

 

 

Login

Username:
Password:

Lost Username / Password?